Skip to Main Content

01.10.18

Minnesota Inmates sue the State for Access to Hepatitis C Antiretrovirals

By | Leave a Comment

5 inmates afflicted with Hepatitis in Minnesota sue the state for highly effective direct acting retrovirals. These drugs have cure rates of 95% but are priced from $26,400 to over $ 100,000 per patient.

For more information: see http://www.startribune.com/the-drug-can-cost-100-000-do-minnesota-inmates-have-a-right-to-get-it/467581443/

Categories:
Tags:
Thematic Areas:

Comments are closed.

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.